04/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

04/04/2024

Apr 4, 2024, 20:02 | Drugs
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Apr 4, 2024, 19:53 | Opinion
Angela C Weyand: Something we aren’t taught in med school but absolutely should be
Angela C Weyand, Clinical Professor of Pediatrics at the University of Michigan Medical School, shared…
Apr 4, 2024, 14:40 | Career
Nick Slack: I'm excited and humbled to announce my new role as Chairman and CEO of The START Center for Cancer Research
Nick Slack, Chairman and CEO of The START Centre for Cancer Research, shared on LinkedIn:…
Apr 4, 2024, 14:31 | Blog
Isabel Mestres: I am very proud of the organizational culture we are building together with the C/Can team
Isabel Mestres, CEO at City Cancer Challenge Foundation, shared a post on LinkedIn: “When City…
Apr 4, 2024, 14:25 | Positive
Alisa Kamalyan: Celebrating 8 years of working in the field of pediatric psycho-oncology
Alisa Kamalyan, Head of Psychosocial Services at the Yeolyan Hematology and Oncology Center, posted on LinkedIn:…
Apr 4, 2024, 14:15 | Blog
Erick Saldanha: Our abstract has been accepted and selected for the ASCO24 Conquer Cancer Merit Award
Erick Saldanha, Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, shared on X/Twitter: "Thrilled to share…
Apr 4, 2024, 14:05 | Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Apr 4, 2024, 13:47 | Insight
Sumanta K. Pal: Excellent real world confirmation of our observations in CONTACT03
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Apr 4, 2024, 13:39 | Blog
Drew Moghanaki: It's reassuring to see longitudinal data aligning with the recommendations we provide patients with stage I NSCLC deciding between surgery and SBRT during usual care
Apr 4, 2024, 13:34 | Drugs
Erman Akkus: NSCLC and anti-EGFR treatments from the ASCO Educational Book
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "NSCLC and anti-EGFR treatments…
All: 28 Posts: 1 - 10